Saudi Arabia Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Biologics, Therapy Devices, Wound Care Dressings), By Ulcer Type (Neuro-ischemic Ulcers, Ischemic, Neuropathic), By End-use, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Market Size & Trends
The Saudi Arabia diabetic foot ulcer treatment market size was estimated at USD 36.3 million in 2024 and is expected t%li%grow at a CAGR of 7.06% from 2025 t%li%2030. Major factors contributing t%li%the growth of Saudi Arabia diabetic foot ulcer treatment industry include, growing cases of diabetes, growing government initiatives and technological advancements in wound care, including bioengineered skin substitutes, negative pressure wound therapy (NPWT), and others.
The rising prevalence of diabetes in Saudi Arabia has significantly heightened the risk of developing diabetic foot ulcers. According t%li%the World Health Organization, the country is projected t%li%be among the top five nations with the highest prevalence of type 2 diabetes mellitus by 2030. This growing burden of diabetes directly contributes t%li%an increase in diabetes-related complications, including foot ulcers. A study published by the National Center for Biotechnology Information (NCBI) highlights that diabetic foot ulcers are the leading cause of lower limb amputations in Saudi Arabia. The risk of ulceration and subsequent amputation increases as diabetic patients age and as the duration of their condition extends, with the likelihood increasing by tw%li%t%li%four times over time. This growing rate further necessitates effective treatment t%li%manage diabetic foot ulcers and reduce associated complications.
Another major factor propelling the market for diabetic foot ulcer treatment in Saudi Arabia is the increasing investment in healthcare infrastructure and advanced medical technologies. The Saudi government, as part of its Vision 2030 initiative, is prioritizing healthcare advancements, leading t%li%improved access t%li%specialized wound care treatments. In addition, the growing presence of multinational medical device companies and collaborations with local healthcare providers are enhancing the availability of innovative treatment options. The expansion of specialized diabetes care centers and the integration of advanced therapies, such as regenerative medicine and smart wound dressings, are further driving the market’s growth.
Lifestyle changes have a significant impact on the increasing prevalence of diabetes and, in turn, the rising cases of diabetic foot ulcers in Saudi Arabia. A sedentary lifestyle, poor dietary habits, and a growing obesity rate are major contributors t%li%the worsening of diabetes-related complications. Limited physical activity and high consumption of processed and sugar-rich foods contribute t%li%insulin resistance, increasing the risk of type 2 diabetes and its associated conditions, including foot ulcers. As a result, the need for effective diabetic foot ulcer treatments is growing, fueling the demand for advanced wound care solutions in the country.
Saudi Arabia Diabetic Foot Ulcer Treatment Market Report Segmentation
This report forecasts revenue growth at the country and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand view research has segmented the Saudi Arabia diabetic foot ulcer treatment market report based on treatment, ulcer type, end-use, and region
Market Size & Trends
The Saudi Arabia diabetic foot ulcer treatment market size was estimated at USD 36.3 million in 2024 and is expected t%li%grow at a CAGR of 7.06% from 2025 t%li%2030. Major factors contributing t%li%the growth of Saudi Arabia diabetic foot ulcer treatment industry include, growing cases of diabetes, growing government initiatives and technological advancements in wound care, including bioengineered skin substitutes, negative pressure wound therapy (NPWT), and others.
The rising prevalence of diabetes in Saudi Arabia has significantly heightened the risk of developing diabetic foot ulcers. According t%li%the World Health Organization, the country is projected t%li%be among the top five nations with the highest prevalence of type 2 diabetes mellitus by 2030. This growing burden of diabetes directly contributes t%li%an increase in diabetes-related complications, including foot ulcers. A study published by the National Center for Biotechnology Information (NCBI) highlights that diabetic foot ulcers are the leading cause of lower limb amputations in Saudi Arabia. The risk of ulceration and subsequent amputation increases as diabetic patients age and as the duration of their condition extends, with the likelihood increasing by tw%li%t%li%four times over time. This growing rate further necessitates effective treatment t%li%manage diabetic foot ulcers and reduce associated complications.
Another major factor propelling the market for diabetic foot ulcer treatment in Saudi Arabia is the increasing investment in healthcare infrastructure and advanced medical technologies. The Saudi government, as part of its Vision 2030 initiative, is prioritizing healthcare advancements, leading t%li%improved access t%li%specialized wound care treatments. In addition, the growing presence of multinational medical device companies and collaborations with local healthcare providers are enhancing the availability of innovative treatment options. The expansion of specialized diabetes care centers and the integration of advanced therapies, such as regenerative medicine and smart wound dressings, are further driving the market’s growth.
Lifestyle changes have a significant impact on the increasing prevalence of diabetes and, in turn, the rising cases of diabetic foot ulcers in Saudi Arabia. A sedentary lifestyle, poor dietary habits, and a growing obesity rate are major contributors t%li%the worsening of diabetes-related complications. Limited physical activity and high consumption of processed and sugar-rich foods contribute t%li%insulin resistance, increasing the risk of type 2 diabetes and its associated conditions, including foot ulcers. As a result, the need for effective diabetic foot ulcer treatments is growing, fueling the demand for advanced wound care solutions in the country.
Saudi Arabia Diabetic Foot Ulcer Treatment Market Report Segmentation
This report forecasts revenue growth at the country and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand view research has segmented the Saudi Arabia diabetic foot ulcer treatment market report based on treatment, ulcer type, end-use, and region
- Treatment Outlook (Revenue, USD Million, 2018 - 2030)
- Wound Care Dressings
- Alginate Dressings
- Hydrofiber Dressings
- Foam Dressings
- Film Dressing
- Hydrocolloid Dressings
- Surgical Dressings
- Hydrogel Dressings
- Biologics
- Growth Factors
- Skin Grafts
- Therapy Devices
- Negative Pressure Wound Therapy
- Ultrasound Therapy
- Antibiotic Medications
- Others
- Ulcer Type Outlook (Revenue, USD Million, 2018 - 2030)
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuro-ischemic Ulcers
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgery centers
- Homecare
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. Ulcer Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Treatment outlook
2.2.2. Ulcer type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of diabetes
3.2.1.2. Aging population
3.2.1.3. Advancements in treatment technology
3.2.1.4. Lifestyle changes
3.2.1.5. Growing R&D activities
3.2.2. Market restraint analysis
3.2.2.1. High cost of treatment
3.3. Saudi Arabia Diabetic Foot Ulcer Treatment Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Saudi Arabia Diabetic Foot Ulcer Treatment Market Movement Analysis
4.3. Global Saudi Arabia Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Wound Care Dressings
4.4.1. Wound care dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1. Alginate dressings
4.4.1.1.1. Alginate dressing market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Hydrofiber dressings
4.4.1.2.1. Hydrofiber dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Foam dressings
4.4.1.3.1. Foam dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Film dressing
4.4.1.4.1. Film dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.5. Hydrocolloid dressings
4.4.1.5.1. Hydrocolloid dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.6. Surgical Dressings
4.4.1.6.1. Surgical dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.7. Hydrogel dressings
4.4.1.7.1. Hydrogel dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Biologics
4.5.1. Biologics market estimates and forecasts 2018 to 2030 (USD Million)
4.5.1.1. Growth factors
4.5.1.1.1. Growth factors market estimates and forecasts 2018 to 2030 (USD Million)
4.5.1.2. Skin grafts
4.5.1.2.1. Skin grafts market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Therapy devices
4.6.1. Therapy devices market estimates and forecasts 2018 to 2030 (USD Million)
4.6.1.1. Negative pressure wound therapy
4.6.1.1.1. Negative pressure wound therapy market estimates and forecasts 2018 to 2030 (USD Million)
4.6.1.2. Ultrasound therapy
4.6.1.2.1. Ultrasound therapy market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Antibiotic medicine
4.7.1. Antibiotic medicine market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET: ULCER TYPE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Saudi Arabia Diabetic Foot Ulcer Treatment Ulcer Type Market Movement Analysis
5.3. Saudi Arabia Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by Ulcer Type, 2018 to 2030 (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Neuropathic Ulcers
5.5.1. Neuropathic ulcers market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Ischemic Ulcers
5.6.1. Ischemic ulcers market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Neuro-ischemic Ulcers
5.7.1. Neuro-ischemic ulcers market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Saudi Arabia Diabetic Foot Ulcer Treatment End Use Market Movement Analysis
6.3. Saudi Arabia Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Ambulatory Surgery Center
6.5.1. Ambulatory surgery center market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Homecare
6.6.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2024
7.4. Company Position Analysis
7.5. Company Categorization (Emerging Players, Innovators and Leaders
7.6. Company Profiles
7.6.1. ConvaTec, Group Plc
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Acelity L.P., Inc.
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. 3M Health Care
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Coloplast Corp.
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Smith & Nephew Plc
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. B Braun Melsungen AG
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. Medline Industries, LP.
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. Molnlycke Health Care AB
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Medtronic Plc
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. Ulcer Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Treatment outlook
2.2.2. Ulcer type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of diabetes
3.2.1.2. Aging population
3.2.1.3. Advancements in treatment technology
3.2.1.4. Lifestyle changes
3.2.1.5. Growing R&D activities
3.2.2. Market restraint analysis
3.2.2.1. High cost of treatment
3.3. Saudi Arabia Diabetic Foot Ulcer Treatment Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Saudi Arabia Diabetic Foot Ulcer Treatment Market Movement Analysis
4.3. Global Saudi Arabia Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Wound Care Dressings
4.4.1. Wound care dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1. Alginate dressings
4.4.1.1.1. Alginate dressing market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Hydrofiber dressings
4.4.1.2.1. Hydrofiber dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Foam dressings
4.4.1.3.1. Foam dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Film dressing
4.4.1.4.1. Film dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.5. Hydrocolloid dressings
4.4.1.5.1. Hydrocolloid dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.6. Surgical Dressings
4.4.1.6.1. Surgical dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.7. Hydrogel dressings
4.4.1.7.1. Hydrogel dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Biologics
4.5.1. Biologics market estimates and forecasts 2018 to 2030 (USD Million)
4.5.1.1. Growth factors
4.5.1.1.1. Growth factors market estimates and forecasts 2018 to 2030 (USD Million)
4.5.1.2. Skin grafts
4.5.1.2.1. Skin grafts market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Therapy devices
4.6.1. Therapy devices market estimates and forecasts 2018 to 2030 (USD Million)
4.6.1.1. Negative pressure wound therapy
4.6.1.1.1. Negative pressure wound therapy market estimates and forecasts 2018 to 2030 (USD Million)
4.6.1.2. Ultrasound therapy
4.6.1.2.1. Ultrasound therapy market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Antibiotic medicine
4.7.1. Antibiotic medicine market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET: ULCER TYPE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Saudi Arabia Diabetic Foot Ulcer Treatment Ulcer Type Market Movement Analysis
5.3. Saudi Arabia Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by Ulcer Type, 2018 to 2030 (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Neuropathic Ulcers
5.5.1. Neuropathic ulcers market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Ischemic Ulcers
5.6.1. Ischemic ulcers market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Neuro-ischemic Ulcers
5.7.1. Neuro-ischemic ulcers market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Saudi Arabia Diabetic Foot Ulcer Treatment End Use Market Movement Analysis
6.3. Saudi Arabia Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Ambulatory Surgery Center
6.5.1. Ambulatory surgery center market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Homecare
6.6.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2024
7.4. Company Position Analysis
7.5. Company Categorization (Emerging Players, Innovators and Leaders
7.6. Company Profiles
7.6.1. ConvaTec, Group Plc
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Acelity L.P., Inc.
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. 3M Health Care
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Coloplast Corp.
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Smith & Nephew Plc
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. B Braun Melsungen AG
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. Medline Industries, LP.
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. Molnlycke Health Care AB
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Medtronic Plc
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
